Moderna
Search results
Oct 16, 2023 · Novavax’s protein-based vaccine is the latest FDA-authorized COVID booster available this fall. Here’s what you should know
Sep 28, 2022 · The Novavax vaccine can be offered to people who have had COVID-19 in the past. But individuals may choose to delay vaccination for 3 months following the infection.
The FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula.
Aug 26, 2022 · “We now have a third type of vaccine in the fight against COVID,” Dr. Fryhofer said during an episode of the “AMA COVID-19 Update” about the Novavax vaccine. “A two-dose series of Novavax protein subunit COVID vaccine is now recommended for unvaccinated” individuals who are 12 or older “for primary vaccination against COVID-19.”
Jun 14, 2021 · Results from a Phase 3 clinical trial enrolling 29,960 adult volunteers in the United States and Mexico show that the investigational vaccine known as NVX-CoV2373 demonstrated 90.4% efficacy in preventing symptomatic COVID-19 disease.
Oct 17, 2023 · The Novavax COVID-19 Vaccine, Adjuvanted, a monovalent vaccine, has been updated to include the spike protein from the SARS-CoV-2 Omicron variant lineage XBB.1.5 (2023-2024 formula).
Oct 4, 2023 · Novavax's updated protein-based COVID-19 vaccine has finally won authorization from the Food and Drug Administration, a late-coming achievement that provides Americans with their only...
